Isoprenyl transferase inhibitors

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 323/41 (2006.01) C07C 323/27 (2006.01) C07C 323/59 (2006.01) C07C 323/60 (2006.01) C07C 323/64 (2006.01) C07D 213/56 (2006.01) C07D 277/04 (2006.01) C07D 307/54 (2006.01) C07D 333/24 (2006.01) C07D 417/10 (2006.01) C07D 417/12 (2006.01) C07F 9/6539 (2006.01) C07K 5/06 (2006.01) C07K 5/065 (2006.01) C07K 5/078 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2185441

Peptidominetic compounds useful in the treatment of Ras-associated human cancers, and other conditions mediated by farnesylated or geranylgeranylated proteins; and synthetic intermediates thereof.

L'invention se rapporte à des composés peptidomimétiques utilisés dans le traitement des cancers humains associés à Ras, et d'autres états induits par des protéines farnesylées ou géranylgéranylées, ainsi qu'à des intermédiaires synthétiques de ces composés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Isoprenyl transferase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Isoprenyl transferase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoprenyl transferase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1602578

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.